Effects of oral adenosine 5′-triphosphate and adenosine in enteric-coated capsules on indomethacin-induced permeability changes in the human small intestine: A randomized cross-over study

BMC Gastroenterology

Volumn 7, Issue , 2007, Pages

  Bours, Martijn J L ^a   Bos, Hilde J ^a   Meddings, Jon B ^b   Brummer, Robert Jan M ^c   van den Brandt, Piet A ^a   Dagnelie, Pieter C ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF ALBERTA   (Canada)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE TRIPHOSPHATE; EUDRAGIT; HYDROXYPROPYLMETHYLCELLULOSE; INDOMETACIN; LACTULOSE; PLACEBO; RHAMNOSE; NONSTEROID ANTIINFLAMMATORY AGENT;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG CAPSULE; DRUG FORMULATION; ENTERIC COATED CAPSULE; FEMALE; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; INTESTINE MUCOSA PERMEABILITY; MALE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; SMALL INTESTINE; URINALYSIS; DRUG EFFECT; ENTERIC COATED TABLET; INTESTINE ABSORPTION; METABOLISM; MICROCAPSULE; ORAL DRUG ADMINISTRATION; PERMEABILITY; REFERENCE VALUE; STEREOISOMERISM; URINE;

ADENOSINE; ADENOSINE TRIPHOSPHATE; ADMINISTRATION, ORAL; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CAPSULES; CROSS-OVER STUDIES; FEMALE; HUMANS; INDOMETHACIN; INTESTINAL ABSORPTION; INTESTINE, SMALL; LACTULOSE; MALE; PERMEABILITY; REFERENCE VALUES; RHAMNOSE; STEREOISOMERISM; TABLETS, ENTERIC-COATED;

EID: 34547437260     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-7-23     Document Type: Article

References (39)

1. Baumgart DC Dignass AU Intestinal barrier function Curr Opin Clin Nutr Metab Care 2002, 5: 685-694 10.1097/00075197-200211000-00012 12394645
2. Smale S Bjarnason I Determining small bowel integrity following drug treatment Br J Clin Pharmacol 2003, 56:284-291 10.1046/ j.1365-2125.2003.01942.x 12919176
3. Bjarnason I Peters TJ Levi AJ Intestinal permeability: Clinical correlates Dig Dis 1986, 4:83-92 3545563
4. Arrieta MC Bistritz L Meddings JB Alterations in intestinal permeability Gut 2006, 55:1512-1520 10.1136/gut.2005.085373 16966705
5. DeMeo MT Mutlu EA Keshavarzian A Tobin MC Intestinal permeation and gastrointestinal disease J Clin Gastroenterol 2002, 34:385-396 10.1097/ 00004836-200204000-00003 11907349
6. Bjarnason I MacPherson A Hollander D Intestinal permeability: An overview Gastroenterology 1995, 108:1566-1581 10.1016/ 0016-5085(95)90708-4 7729650
7. Bjarnason I O'Morain C Levi AJ Peters TJ Absorption of 51chromium-labeled ethylenediaminetetraacetate in inflammatory bowel disease Gastroenterology 1983, 85:318-322 6407889
8. Sanderson IR Boulton P Menzies I Walker-Smith JA Improvement of abnormal lactulose/rhamnose permeability in active Crohn's disease of the small bowel by an elemental diet Gut 1987, 28:1073-1076 1433221 3678965
9. Teahon K Smethurst P MacPherson AJ Levi J Menzies IS Bjarnason I Intestinal permeability in Crohn's disease and its relation to disease activity and relapse following treatment with an elemental diet Eur J Gastroenterol Hepatol 1993, 5:79-84 10.1097/00042737-199302000-00004
10. May GR Sutherland LR Meddings JB Is small intestinal permeability really increased in relatives of patients with Crohn's disease? Gastroenterology 1993, 104:1627-1632 8500719
11. Arnott ID Kingstone K Ghosh S Abnormal intestinal permeability predicts relapse in inactive Crohn disease Scand J Gastroenterol 2000, 35:1163-1169 10.1080/003655200750056637 11145287
12. Wyatt J Vogelsang H Hubl W Waldhoer T Lochs H Intestinal permeability and the prediction of relapse in Crohn's disease Lancet 1993, 341:1437-1439 10.1016/0140-6736(93)90882-H 8099141
13. Prytz H Benoni C Tagesson C Does smoking tighten the gut? Scand J Gastroenterol 1989, 24:1084-1088 2512634
14. Aabakken L Cr-ethylenediaminetetraacetic acid absorption test. Methodologic aspects Scand J Gastroenterol 1989, 24:351-358 2499921
15. Bjarnason I Peters TJ Wise RJ The leaky gut of alcoholism: Possible route of entry for toxic compounds Lancet 1984, 1:179-182 10.1016/ S0140-6736(84)92109-3 6141332
16. Wallace JL Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years Gastroenterology 1997, 112:1000-1016 10.1053/ gast.1997.v112.pm9041264 9041264
17. Bjarnason I Hayllar J MacPherson AJ Russell AS Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans Gastroenterology 1993, 104:1832-1847 8500743
18. Davies NM Review article: Non-steroidal anti-inflammatory drug-induced gastrointestinal permeability Aliment Pharmacol Ther 1998, 12:303-320 10.1046/j.1365-2036.1998.00300.x 9690719
19. Somasundaram S Hayllar H Rafi S Wrigglesworth JM Macpherson AJ Bjarnason I The biochemical basis of non-steroidal anti-inflammatory drug-induced damage to the gastrointestinal tract: A review and a hypothesis Scand J Gastroenterol 1995, 30:289-299 7610343
20. Bjarnason I Smethurst P Macpherson A Walker F McElnay JC Passmore AP Menzies IS Glucose and citrate reduce the permeability changes caused by indomethacin in humans Gastroenterology 1992, 102:1546-1550 1568563
21. Bjarnason I Williams P Smethurst P Peters TJ Levi AJ Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine Gut 1986, 27:1292-1297 1434083 3466837
22. Bjarnason I Smethurst P Fenn CG Lee CE Menzies IS Levi AJ Misoprostol reduces indomethacin-induced changes in human small intestinal permeability Dig Dis Sci 1989, 34:407-411 10.1007/BF01536263 2493366
23. Bours MJ Troost FJ Brummer RJ Bast A Dagnelie PC Local effect of adenosine 5'-triphosphate on indomethacin-induced permeability changes in the human small intestine Eur J Gastroenterol Hepatol 2007, 19:245-250 10.1097/MEG.0b013e328011093c 17301652
24. van Nieuwenhoven MA Geerling BJ Deutz NE Brouns F Brummer RJ The sensitivity of the lactulose/rhamnose gut permeability test Eur J Clin Invest 1999, 29:160-165 10.1046/j.1365-2362.1999.00421.x 10093003
25. Odashima M Bamias G Rivera-Nieves J Linden J Nast CC Moskaluk CA Marini M Sugawara K Kozaiwa K Otaka M Watanabe S Cominelli F Activation of A2a adenosine receptor attenuates intestinal inflammation in animal models of inflammatory bowel disease Gastroenterology 2005, 129:26-33 10.1053/ j.gastro.2005.05.032 16012931
26. Ralevic V Burnstock G Receptors for purines and pyrimidines Pharmacol Rev 1998, 50:413-492 9755289
27. Pals KL Chang RT Ryan AJ Gisolfi CV Effect of running intensity on intestinal permeability J Appl Physiol 1997, 82:571-576 9049739
28. Sheid B Trazodone, a nontricyclic antidepressant, is an inhibitor of adenosine deaminase Res Commun Chem Pathol Pharmacol 1985, 47:149-152 3983468
29. Herken H Akyol O Yilmaz HR Tutkun H Savas HA Ozen ME Kalenderoglu A Gulec M Nitric oxide, adenosine deaminase, xanthine oxidase and superoxide dismutase in patients with panic disorder: Alterations by antidepressant treatment Hum Psychopharmacol 2006, 21:53-59 10.1002/ hup.742 16329160
30. Parviainen I Takala J Jakob SM Does fluid loading influence measurements of intestinal permeability? Crit Care 2005, 9: R234-7 1175885 15987395 10.1186/cc3511
31. Huyghebaert N Vermeire A Remon JP Alternative method for enteric coating of HPMC capsules resulting in ready-to-use enteric-coated capsules Eur J Pharm Sci 2004, 21:617-623 10.1016/j.ejps.2004.01.002 15066662
32. Swagerty DL Jr. Walling AD Klein RM Lactose intolerance Am Fam Physician 2002, 65:1845-1850 12018807
33. Meddings JB Gibbons I Discrimination of site-specific alterations in gastrointestinal permeability in the rat Gastroenterology 1998, 114:83-92 10.1016/S0016-5085(98)70636-5 9428222
34. Troost FJ Saris WH Brummer RJ Recombinant human lactoferrin ingestion attenuates indomethacin-induced enteropathy in vivo in healthy volunteers Eur J Clin Nutr 2003, 57:1579-1585 10.1038/sj.ejcn.1601727 14647223
35. Saweirs WM Andrews DJ Low-Beer TS The double sugar test of intestinal permeability in the elderly Age Ageing 1985, 14:312-315 10.1093/ageing/ 14.5.312 4050610
36. Saltzman JR Kowdley KV Perrone G Russell RM Changes in small-intestine permeability with aging J Am Geriatr Soc 1995, 43:160-164 7836641
37. Smith A Heckelman PE The Merck Index: An encyclopedia of chemicals, drugs and biologics New York, Merck Research Laboratories Division of Merck & Co., Inc. O'Neil MJ and Budavari S Thirteenth Edition 2001
38. Somasundaram S Sigthorsson G Simpson RJ Watts J Jacob M Tavares IA Rafi S Roseth A Foster R Price AB Wrigglesworth JM Bjarnason I Uncoupling of intestinal mitochondrial oxidative phosphorylation and inhibition of cyclooxygenase are required for the development of NSAID-enteropathy in the rat Aliment Pharmacol Ther 2000, 14:639-650 10.1046/ j.1365-2036.2000.00723.x 10792129
39. Somasundaram S Rafi S Hayllar J Sigthorsson G Jacob M Price AB Macpherson A Mahmod T Scott D Wrigglesworth JM Bjarnason I Mitochondrial damage: A possible mechanism of the "topical" phase of NSAID induced injury to the rat intestine Gut 1997, 41:344-353 1891477 9378390